Clinical benefit of anti-PD-(L)1 immunotherapies in advanced cancer in France: a population-based estimate from 2014 to 2021-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical benefit of anti-PD-(L)1 immunotherapies in advanced cancer in France: a population-based estimate from 2014 to 2021

Published:2024-02 Issue:2 Volume:9 Page:102240
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Grumberg V.^ORCID,Cotté F.-E.,Giroux-Leprieur E.,Gaudin A.-F.^ORCID,Lebbé C.^ORCID,Borget I.^ORCID

Funder

Bristol-Myers Squibb

Publisher

Elsevier BV

Reference22 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Direction de la recherche, des études de l’évaluation et des statistiques. L’état de santé de la population en France. Rapport 2017,2017

3. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study;Cardoso;Lancet Oncol,2021

4. Effects of organized colorectal cancer screening on cancer incidence and mortality in a large community-based population;Levin;Gastroenterology,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in lymphatic metastasis of non-small cell lung cancer;Cell Communication and Signaling;2024-04-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP